176,292 Shares in Globe Life Inc. $GL Acquired by Todd Asset Management LLC

Todd Asset Management LLC bought a new position in shares of Globe Life Inc. (NYSE:GL) during the fourth quarter, Holdings Channel.com reports. The fund bought 176,292 shares of the company’s stock, valued at approximately $24,656,000.

A number of other large investors have also recently made changes to their positions in the company. Swedbank AB increased its stake in shares of Globe Life by 15.6% during the fourth quarter. Swedbank AB now owns 962,000 shares of the company’s stock worth $134,545,000 after buying an additional 130,000 shares during the period. Leonteq Securities AG purchased a new position in Globe Life in the fourth quarter valued at approximately $161,000. Handelsbanken Fonder AB increased its stake in Globe Life by 23.1% in the fourth quarter. Handelsbanken Fonder AB now owns 75,235 shares of the company’s stock valued at $10,522,000 after purchasing an additional 14,135 shares during the last quarter. Resona Asset Management Co. Ltd. increased its stake in Globe Life by 15.3% in the fourth quarter. Resona Asset Management Co. Ltd. now owns 1,008 shares of the company’s stock valued at $143,000 after purchasing an additional 134 shares during the last quarter. Finally, ProShare Advisors LLC increased its stake in Globe Life by 2.6% in the fourth quarter. ProShare Advisors LLC now owns 17,216 shares of the company’s stock valued at $2,408,000 after purchasing an additional 439 shares during the last quarter. 81.61% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have commented on GL. JPMorgan Chase & Co. increased their price target on shares of Globe Life from $180.00 to $181.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. Weiss Ratings upgraded shares of Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research note on Wednesday, May 13th. Evercore set a $157.00 price target on shares of Globe Life in a research note on Wednesday, February 18th. Keefe, Bruyette & Woods reiterated a “moderate buy” rating and issued a $168.00 price target on shares of Globe Life in a research note on Thursday, March 26th. Finally, Morgan Stanley raised their target price on shares of Globe Life from $176.00 to $181.00 and gave the stock an “overweight” rating in a research report on Thursday. Two investment analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of $173.22.

Globe Life Stock Performance

Shares of Globe Life stock opened at $156.46 on Monday. The firm’s fifty day simple moving average is $147.24 and its 200-day simple moving average is $141.99. The stock has a market capitalization of $12.15 billion, a price-to-earnings ratio of 10.82 and a beta of 0.50. Globe Life Inc. has a 12 month low of $116.73 and a 12 month high of $157.92. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07.

Globe Life (NYSE:GL) last announced its earnings results on Wednesday, April 22nd. The company reported $3.43 EPS for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). The business had revenue of $1.56 billion during the quarter, compared to analyst estimates of $1.56 billion. Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The business’s revenue was up 5.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $3.07 earnings per share. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. As a group, equities analysts forecast that Globe Life Inc. will post 15.57 earnings per share for the current year.

Globe Life Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be issued a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life’s payout ratio is presently 9.13%.

Insider Buying and Selling at Globe Life

In related news, EVP Michael Clay Majors sold 34,000 shares of the stock in a transaction on Friday, April 24th. The stock was sold at an average price of $153.81, for a total transaction of $5,229,540.00. Following the completion of the sale, the executive vice president directly owned 53,518 shares of the company’s stock, valued at $8,231,603.58. This trade represents a 38.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Thomas Peter Kalmbach sold 15,637 shares of the stock in a transaction on Monday, May 11th. The stock was sold at an average price of $153.65, for a total value of $2,402,625.05. Following the sale, the chief financial officer directly owned 45,335 shares of the company’s stock, valued at approximately $6,965,722.75. This represents a 25.65% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 106,550 shares of company stock valued at $16,140,745. Insiders own 2.11% of the company’s stock.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.